Patient Reported Outcomes (PROs)

Use of PROs to improve diagnosis, treatment, and care of patients with MS.

 

Outcomes Study

This study is a multi-center observational real-world platform which aims to integrate data from multiple sources to facilitate patient and provider engagement, shared decision making, and participation in high-priority research questions, as well as identify a core set of patient reported outcomes (PROs) that correlates with disease progression and activity

Partner: Tornatore, MedStar Georgetown; English, MS Center of Atlanta

Status: Ongoing

Outcomes Study DescriptionOutcomes Study Description
Outcomes Study Description

Outcomes Study InfographicOutcomes Study Infographic
Outcomes Study Infographic

Poster presented at AAN 2023Poster presented at AAN 2023
Poster presented at AAN 2023

Poster presented at ECTRIMS 2023Poster presented at ECTRIMS 2023
Poster presented at ECTRIMS 2023

 

Next Gen MS

This study will use PRO data collected in the MS-LINK Outcomes study in a feed-forward method to evaluate if PRO data can be practically utilized within real healthcare systems to improve quality of life or delay disability progression in adults living with MS

Partner: Oliver, Dartmouth

Status: Ongoing

Next Gen MS Study DescriptionNext Gen MS Study Description
Next Gen MS Study Description

Poster presented at CMSC 2023Poster presented at CMSC 2023
Poster presented at CMSC 2023

Poster presented at ECTRIMS 2023Poster presented at ECTRIMS 2023
Poster presented at ECTRIMS 2023

 

DISCOMS Extension

This study aims to provide data on the durability of disease inactivity, and potential risks, after discontinuing DMT(s) in MS

Partner: Cutter, University of Alabama; Corboy, University of Colorado

Status: Complete

DISCOMS Extension Study DescriptionDISCOMS Extension Study Description
DISCOMS Extension Study Description

Poster presented at ECTRIMS 2023Poster presented at ECTRIMS 2023
Poster presented at ECTRIMS 2023